Search bioRxiv⌕ Search

bioRxiv · 10.1101/2020.02.09.940460

Lower intake of animal-based products links to improved weight status, independent of depressive symptoms and personality in the general population

Abstract

BackgroundRestricting animal-based products from diet may exert beneficial effects on weight status, however whether this is also true for emotional health is unclear. Moreover, differential personality traits may underlie restrictive eating habits and therefore potentially confound diet-health associations. To systematically assess whether restrictive dietary intake of animal-based products relates to lower weight and higher depressive symptoms, and how this is linked to personality traits in the general population. MethodsCross-sectional data was taken from the baseline LIFE-Adult study collected from 2011-2014 in Leipzig, Germany (n = 8943). Main outcomes of interest were 12-month dietary frequency of animal-derived products measured using a Food Frequency Questionnaire (FFQ), body mass index (BMI) (kg/m2), and the Center of Epidemiological Studies Depression Scale (CES-D). Personality traits were assessed in a subsample of n = 7906 using the Five Factor Inventory (NEO-FFI). FindingsHigher restriction of animal-based product intake was associated with a lower BMI (age-, sex- and education-adjusted, n = 8943; {beta} = -.07, p < .001), but not depression score. Personality, i.e. lower extraversion (F (1,7897) = 9.8, p = .002), was related to frequency of animal product intake. Further, not diet but personality was significantly associated with depression, i.e. higher neuroticism ({beta} = .024), lower extraversion ({beta} = -.006), lower agreeableness ({beta} = -.001), lower conscientiousness ({beta} = -.007) and higher BMI ({beta} = .004) (all p < .001, overall model, R2 = .21). The beneficial association with lower weight seemed to be driven by the frequency of meat product intake and not secondary animal products. Likewise, the overall number of excluded food items from the individual diet was associated with a lower BMI (age-, sex- and education-adjusted, n = 8938, {beta} = -.15, p < .001) and additionally with lower depression scores ({beta} = -.004, t = -4.1, p < .001, R2 = .05, corrected for age, sex and education), also when additionally correcting for differences in personality traits ({beta} = -.003, t = -2.7, p = .007, R2 = .21). InterpretationHigher restriction of animal-based products in the diet was significantly associated with a lower BMI, but not with depressive symptoms scores in a large well-characterized population-based sample of adults. In addition, we found that certain personality traits related to restricting animal-based products - and that those traits, but not dietary habits, explained a considerable amount of variance in depressive symptoms. Upcoming longitudinal studies need to confirm these findings and to test the hypothesis if restricting animal-based products, esp. primary animal products ((processed) meat, wurst), conveys benefits on weights status, hinting to a beneficial relationship of animal-based restricted diets in regard to prevention and treatment of overweight and obesity. FundingWe thank all study participants. We very much appreciate the help of the physicians who performed the clinical examinations and data collection, in particular Ulrike Scharrer, Annett Wiedemann, Kerstin Wirkner and her team. This work was supported by LIFE--Leipzig Research Centre for Civilisation Diseases, University of Leipzig. LIFE is funded by means of the European Union, by means of the European Social Fund (ESF), by the European Regional Development Fund (ERDF), and by means of the Free State of Saxony within the framework of the excellence initiative. This work was supported by a scholarship (EM) by the German Federal Environmental Foundation and by the grants of the German Research Foundation contract grant number CRC 1052 "Obesity mechanisms" Project A1 (AV) and WI 3342/3-1 (AVW). The corresponding author had full access to all the data in the included in the analysis and had final responsibility for the decision to submit for publication. Graphical abstract O_FIG O_LINKSMALLFIG WIDTH=146 HEIGHT=200 SRC="FIGDIR/small/940460v1_ufig1.gif" ALT="Figure 1"> View larger version (23K): org.highwire.dtl.DTLVardef@1f81d8org.highwire.dtl.DTLVardef@85bd35org.highwire.dtl.DTLVardef@48fd83org.highwire.dtl.DTLVardef@1fbc053_HPS_FORMAT_FIGEXP M_FIG C_FIG

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Medawar, E., Enzenbach, C., Roehr, S., Villringer, A., Riedel-Heller, S., Witte, A. V.. 2020-02-10. Lower intake of animal-based products links to improved weight status, independent of depressive symptoms and personality in the general population. https://doi.org/10.1101/2020.02.09.940460

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

Rab10 and Arhgef7 interact to promote axon extension by linking vesicle supply and exocytosis

The formation of functional neural circuits begins with the extension of a single axon by immature neurons. Axon elongation requires an expansion of the plasma membrane that depends on the polarization of vesicle trafficking and exocytosis. It is not completely understood how the increased transport of vesicles into the growing axon is linked to their subsequent insertion into the plasma membrane. An analysis of early stages of neuronal differentiation indicates that an asymmetry in neurite length precedes axon specification and the accumulation of PPVs in the nascent axon. We show that increasing the transport of vesicles in unpolarized neurons is sufficient to promote the extension of additional axons. This effect indicates that an increased supply of vesicles stimulates their subsequent insertion into the membrane to allow neurite growth. The link between vesicle transport and exocytosis is mediated by the interaction of Rab10 with Arhgef7. Rab10 stimulates Arhgef7 activity on PPVs as a GEF for Cdc42b to promote axon extension through exocyst-dependent exocytosis, suggesting that their interaction links the increased supply of PPVs to their exocytosis.

neuroscience↗

Subcellular Spatial Profiling Unveils Links Between Neuritic Plaques with Selective Tau Vulnerability in Alzheimer's Disease

Alzheimer's disease (AD) features widespread extracellular amyloid-{beta} plaques but selective intraneuronal tau accumulation in cortical layers II/III and V, while layer IV remains relatively resistant. Here, we combined subcellular spatial transcriptomics with co-registered A{beta} and pTau immunohistochemistry to determine why neurons exposed to comparable plaque-associated pathology differ in somatic pTau accumulation. Plaque-associated neuritic stress occurred similarly across layers, but layer IV neurons showed attenuated pTau accumulation and reduced somatic expression of a shared neurite-soma stress program involving DCTN1, CALM3, NORAD, and PIN1. Trajectory analysis within layers identified tau-vulnerable and resistant neuronal states implicating calcium signaling, retrograde transport, and lysosomal function. Notably, astrocytic APOE-neuronal LRP1 co-expression increased significantly along the pTau-vulnerable trajectory, and APOE {epsilon}4 was associated with stronger coupling of local plaque pathology to pTau-associated molecular programs. These findings reveal neuronal programs and neuron-glia interactions underlying selective tau vulnerability and resistance in AD, highlighting potential tau-targeting therapeutics.

neuroscience↗

Widespread oscillatory suppression in autism persists in the absence of psychotropic medication.

Purpose: Investigate the neural oscillatory activity associated with autism spectrum disorder (ASD) using electroencephalographic (EEG) recordings in children and adolescents. Compare the corresponding oscillatory power between ASD patients taking psychotropic medication with a drug-naive group. Methods: ASD diagnosis was done using DSM-IV and CARS (Childhood Autism Rating Scale). EEG recordings employed 22 scalp electrodes (10/20 system). ASD vs. neurotypical groups were matched for sex and age (5 females; average age: ~10 years old). We analyzed the resting state (eyes open) EEG power spectrum during ~2-minute recordings. The multitaper FFT method was used to estimate spectral power for the delta, theta, alpha, beta and gamma frequency bands. We pooled together data from several electrodes to compute comprehensive power spectra and assess the oscillatory behavior of macro brain regions. Results: We observed widespread (~4Hz - 20Hz) oscillatory suppression comprising the theta, alpha and beta frequency bands. The most widespread and robust ASD-associated power suppression was in the high theta and alpha bands. Delta and gamma bands showed no significant power change for any of the brain regions studied. Results from a subgroup of patients (N = 9) who never used psychotropics confirmed these findings, indicating that they are not an artifact of medication. Conclusion: Suppression in theta, alpha and beta oscillations may offer insights into the neurophysiological underpinnings of autism and could be used as an accessible and comprehensive tool in ASD diagnosis, regardless of the patients being or not on medication.

neuroscience↗